# Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study

> **NCT01891318** · PHASE1,PHASE2 · RECRUITING · sponsor: **Case Comprehensive Cancer Center** · enrollment: 36 (estimated)

## Conditions studied

- Tumors Metastatic to Brain

## Interventions

- **RADIATION:** radiosurgery
- **PROCEDURE:** therapeutic conventional surgery
- **PROCEDURE:** quality-of-life assessment

## Key facts

- **NCT ID:** NCT01891318
- **Lead sponsor:** Case Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2013-07-03
- **Primary completion:** 2026-09
- **Final completion:** 2026-09
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2026-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01891318

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01891318, "Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study". Retrieved via AI Analytics 2026-07-23 from https://api.ai-analytics.org/clinical/NCT01891318. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*